BioSpace News Archive

Business

AMYRIS ANNOUNCES APPOINTMENT OF ANA DUTRA TO BOARD OF DIRECTORS

Amyris, Inc. today announced the appointment of Ms. Ana Dutra as its newest independent member of the Amyris Board of Directors, effective January 21, 2022.

January 27, 2022
·
3 min read
Drug Development

BridgeBio Pharma Announces Dosing of First Patient in Phase 1/2 Trial of Investigational Gene Therapy for Congenital Adrenal Hyperplasia (CAH)

BridgeBio today announced that the first patient has been dosed in ADventure, its Phase 1/2 clinical trial of BBP-631.

January 27, 2022
·
9 min read
Business

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022

Apyx Medical Corporation today announced that financial results for the fourth quarter and fiscal year 2021 will be released before the market opens on Thursday, March 17th.

January 27, 2022
·
2 min read
BioCapital

Diana Davis Spencer Foundation Pledges $5M to Foundation Fighting Blindness for Inherited Retinal Disease Research

The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Diana Davis Spencer Foundation.

January 27, 2022
·
2 min read
Deals

BioVentrix Expands Heart Failure Treatment Portfolio with Acquisition of MateraCor, Inc.

BioVentrix, Inc. today announced that it has acquired MateraCor, Inc.

January 27, 2022
·
4 min read
Business

Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and WebcastCall scheduled for Thursday, February 10th at 4:30 pm Eastern Time

Beyond Air, Inc. today announced that it will report financial results for its third fiscal quarter ended December 31, 2021 on Thursday, February 10, 2022.

January 27, 2022
·
4 min read
Business

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

Nautilus Biotechnology, Inc. today announced it will report financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24th , 2022.

January 27, 2022
·
1 min read
Business

Cognito Therapeutics and Providence Health Plan Launch Phase 3 Study to Evaluate Disease-Modifying Therapeutic in Mild Cognitive Impairment

Cognito Therapeutics and Providence Health Plan today announced a collaboration to conduct a Phase 3 study of Cognito’s breakthrough, non-invasive disease-modifying therapy for patients with Mild Cognitive Impairment (MCI).

January 27, 2022
·
3 min read
Biotech Bay

Graphite Bio Announces Participation in Upcoming Investor Conferences - Jan 27, 2022

Graphite Bio, Inc., a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, announced participation in the following upcoming investor conferences.

January 27, 2022
·
1 min read
Deals

Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health, Welcomes New Chief Analytics Officer and President of Provider Solutions

Apollo Medical Holdings, Inc. announced that it has acquired 100% of the fully diluted capitalization of Orma Health, Inc., and Provider Growth Solutions LLC in accordance with an agreement between ApolloMed, Orma Health and certain equity holders of Orma Health.

January 27, 2022
·
7 min read